Australia's largest stock trading and investment forum Australia's #1 stock forum

ALA

4.62%

15.5¢ arovella therapeutics limited

Ann: Appendix 4C - quarterly, page-23

First 23 Last

Share
Profile

Follow
Bluebush

2,310 Posts.

332

11/02/15

21:21

Post #: 14739049
Share

Originally posted by livas1 ↑

Hi bluebush

They have a tad over $3m in the bank and $450k in a line of credit and expect it to last for 12 months.
So forget about the credit line and lets assume that this means they could function on a cash outflow of $750k per quarter for 4 periods to exhaust the $3m in the bank.

Well lets take the $900k from the most recent quarter and see what we can do with it to drop it by $150k to get to the $750k required

Customer receipts were $1.927m and this has been growing by over 20%. Lets assume the growth rate halves for the next 4 quarters and sales grow by only 10% a year. I think this is conservative given the penetration of the new product range has only just started and also the east coast which the company has said could add $3-4m in revenues.

$1.927m becomes $2.12m at the end of the next quarter, an increase of $190k
$2.12m then becomes $2.33m and an increase of $210k
$2.33m then becomes $2.56m – an increase of $230k
$2.56m then becomes $2.82m – an increase of $260k

So if we “need” an extra $600k (4x$150k) and this demonstrates that we will receive an extra $890k in revenue before costs. Not enough to meet the target.

So lets do it on a 20% growth rate:

$1.927 becomes $2.31m – an increase of $380k
$2.31m becomes $2.77m – an increase of $460k
$2.77m becomes $3.33m – an increase of $560k
$3.33m becomes $4m – an increase of $670k

So a total increase of $2.07m in revenue

What margin do we apply?
Well I recall reading some time ago that the margin on this business was around 10-15%. So 15% gets us net $300k. I would think that the sunk costs in inventory build-up for the east coast centre in Brisbane, plus the fact there will be some operating leverage given the fixed costs that already exist in the business means that you could boost this by another 15%.
So another $300k gives us the $600k that I mentioned earlier and the affirmation of the 12 month target.

This is all very crude and I know not complete and there are plenty of assumptions, and this does not include a) any use of the credit lines b) any exercise of options and c) any capital injection from a deal that the company signs in the whole of this year.

I feel very comfortable that based on what we know now about the company’s plans and strategy that there wont be any capital raising.

Expand

Hi livas1, I agree that based on past performance WC has the potential to add another 20% this quarter. I'm a firm believer that WC is being managed very efficiently by Billingham and crowd.

At the end of the day however I'm not sure that the combined entity will not continue as a loss making company during CY2015. Time will tell and you're quite right if there is a deal signed with dollars attached then the game changes. Before then, I hope you are correct.

Thanks for the analysis.

SUD Price at posting: 4.2¢ Sentiment: Hold Disclosure: Held
2 Upvote

0 Great analysis

Reply

Top Stories

ASX Market Open: Weak tech results and jobs data in the US push Australian futures down

BOE

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

LTP

LTR Pharma doses first patient with SPONTAN viagra nasal spray via TGA

Is oil undervalued?

First 23 Last

Add ALA (ASX) to my watchlist

(20min delay)
Last 15.5¢		Change -0.008(4.62%)		Mkt cap ! $163.0M

Open	High	Low	Value	Volume
16.0¢	16.3¢	15.5¢	$249.5K	1.583M

Buyers (Bids)

No.	Vol.	Price($)
1	2289	15.5¢

Sellers (Offers)

Price($)	Vol.	No.
16.0¢	62493	1

View Market Depth

No.	Vol.	Price($)
1	2289	0.155
10	686665	0.150
6	398370	0.145
5	269544	0.140
4	157094	0.135

Price($)	Vol.	No.
0.160	62493	1
0.165	97705	3
0.170	616426	6
0.175	752769	4
0.180	617450	5

Last trade - 15.30pm 02/08/2024 (20 minute delay)

ALA (ASX) Chart

Ann: Appendix 4C - quarterly, page-23

ASX Market Open: Weak tech results and jobs data in the US push Australian futures down

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

LTR Pharma doses first patient with SPONTAN viagra nasal spray via TGA

Is oil undervalued?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News

Ann: Appendix 4C - quarterly, page-23

Top Stories

ASX Market Open: Weak tech results and jobs data in the US push Australian futures down

Uranium prices on the NYMEX are stable, but ASX uranium stocks are sinking on Friday. The answer lies in Kazakhstan

Week 31 Wrap: JORC rules to get tougher; RBA rate hike chance 50/50; US Fed Sept cut still the quo

LTR Pharma doses first patient with SPONTAN viagra nasal spray via TGA

Is oil undervalued?

Featured News

Buyers (Bids)

Sellers (Offers)

Featured News